very positive article from Adam F.
Seeking Alpha Market Currents 4/19/13 Canaccord says "the CF corrector discovery platform" has been validated and the "likelihood for trial success and uptake" has increased. Canaccord raises target to $96
thank u.
$100
loaded up myself. Instutions will want this badly.
very strong here
agree
yes!
great for VVUS
agree
nice
Article: Helping the DEA With Arena Pharmaceuticals' Belviq's Final Scheduling
By: Chris Roberts Seeking Alpha
Belvig:
1) The drug has marginal efficacy, and will be used in combination with phentarmine
2) The drug is like LSD, and will be abused in the same manner.
3) The drug is addictive, and patient population (obese people) have a proclivity to addictions.
4) The drug will be used in large quantities to achieve a "high".
arna board saying DEA not going to give ARNA DEA.
#$%$ getting out.
this sucks !!!
looks like VVUS about to takeoff here. bought yesterday and added more later in the day.
$$
wow there everywhere..lol